- জেনেরিক নাম
- Apixaban
- শক্তি
- 2.5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Synovia Pharma PLC.
Copixa 2.5 mg Tablet
Copixa 2.5 mg Tablet সম্পর্কে
Copixa 2.5 mg হলো Apixaban-এর একটি ব্র্যান্ড, শক্তি ২.৫ mg, ট্যাবলেট আকারে। এটি তৈরি করে Synovia Pharma PLC। Apixaban-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Apixaban-এর ১৬টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Antixa 2.5 mg Tablet-এর, প্রতি ইউনিট ৳ ১০.০০।
Copixa 2.5 mg Tablet কী?
Copixa 2.5 mg is a tablet manufactured by Synovia Pharma PLC. The active ingredient is apixaban, which belongs to a group of medicines that reduce the blood's ability to clot. It works by blocking a clotting factor called factor Xa. Doctors use it to lower the chance of stroke in people with an irregular heartbeat called nonvalvular atrial fibrillation. It is also used to prevent clots after hip or knee replacement surgery and to treat deep vein thrombosis. The dose and length of treatment are decided by your doctor.
Copixa 2.5 mg-এর ব্যবহার
Copixa 2.5 mg is used in adults for a few specific clot-related problems. It helps reduce the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation. It is also used to prevent deep vein thrombosis, which can lead to pulmonary embolism, after hip or knee replacement surgery. In addition, it is used to treat deep vein thrombosis. Your doctor will confirm whether it is suitable for you.
Copixa 2.5 mg কীভাবে ব্যবহার করবেন
Take Copixa 2.5 mg exactly as your doctor tells you. Swallow the tablet with water. The doctor decides the dose, how often to take it, and how long the course lasts. Do not stop taking it without talking to your doctor first, because stopping suddenly can raise the risk of clots. If you miss a dose, ask your doctor or pharmacist what to do. Keep the tablets in a dry place below 30°C, away from light and out of reach of children.
Copixa 2.5 mg-এর পার্শ্বপ্রতিক্রিয়া
Copixa 2.5 mg can cause a skin rash or a severe allergic reaction. Because it reduces clotting, bleeding is a concern with this type of medicine. Tell your doctor or pharmacist about any side effect you notice, especially if it worries you or does not go away. They can advise you on what to do. Do not ignore unusual symptoms, and seek medical help if you feel unwell.
সতর্কতা ও নিরাপত্তা
Before taking Copixa 2.5 mg, tell your doctor about all your health conditions and medicines. It is not suitable for people with active pathological bleeding or a severe allergic reaction to apixaban. Do not stop the medicine without medical advice, as this can increase the risk of stroke. If you are pregnant, planning pregnancy, or breastfeeding, ask your doctor first. There is limited information on its use in pregnancy and breastfeeding. Your doctor will weigh the benefits and risks. Always check with your doctor or pharmacist if you are unsure.
সাধারণ প্রশ্ন
What does the generic name apixaban mean?
Apixaban is the generic name of the active ingredient in Copixa 2.5 mg. It is a factor Xa inhibitor, meaning it blocks a specific clotting factor to help prevent blood clots. Generic names are used to identify the medicine itself, separate from brand names.
What is Copixa 2.5 mg used for and what kind of medicine is it?
Copixa 2.5 mg is an anticoagulant tablet. It is used to reduce the risk of stroke in nonvalvular atrial fibrillation, to prevent deep vein thrombosis after hip or knee replacement surgery, and to treat deep vein thrombosis. Your doctor will decide if it is right for you.
Which medicines may interact with Copixa 2.5 mg?
Copixa 2.5 mg can interact with other medicines that affect the same enzymes or transport proteins in the body. These include some antifungal, antiviral, and antibiotic medicines. Always tell your doctor or pharmacist about every medicine you take, including over-the-counter products, so they can check for interactions.
What should I do if I miss a dose of Copixa 2.5 mg?
If you miss a dose, ask your doctor or pharmacist for advice on what to do. Do not double the next dose on your own. They will tell you whether to take the missed tablet or skip it, based on your treatment plan.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Apixaban is a factor Xa inhibitor indicated:- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery ... Read more
- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery
- For the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Apixaban acts by inhibiting coagulation, and thus prevents development of blood clots. As a result of FXa inhibition, apixaban prolongs clotting tests such as prothrombin time (PT), INR, and activated partial thromboplastin time (aPTT). Changes observed in these clotting tests at the expected therapeutic dose, however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of apixaban.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Recommended Dose: The recommended dose of Apixaban for most patients is 5 mg taken orally twice daily.Dosage Adjustments: The recommended dose of Apixaban is 2.5 mg twice daily in patients with any 2 of the following characteristics: age ≥80 years, body weight ≤60 kg, serum creatinine ≥1.5mg/dl.
CYP3A4 and P-gp inhibitors: When Apixaban is coadministered with drugs that are strong dual inhibitors of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) (e.g. ketoconazole, itraconazole, ritonavir, clarithromycin) the recommended dose is 2.5 mg twice daily.
Missed Dose: If a dose of Apixaban is not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice-daily administration should be resumed. The dose should not be doubled to make up for a missed dose.
Discontinuation for Surgery and Other Interventions: Apixaban should be discontinued at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding. Apixaban should be discontinued at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding or where the bleeding would be non-critical in location and easily controlled.
Switching from or to Apixaban: Switching from warfarin to Apixaban: Warfarin should be discontinued and Apixaban started when the international normalized ratio (INR) is below 2.0.
Switching from Apixaban to warfarin: Apixaban affects INR, so that INR measurements during co-administration with warfarin may not be useful for determining the appropriate dose of warfarin. If continuous anticoagulation is necessary, discontinue Apixaban and begin both a parenteral anticoagulant and warfarin at the time the next dose of Apixaban would have been taken, discontinuing the parenteral anticoagulant when INR reaches an acceptable range.
Switching between Apixaban and anticoagulants other than warfarin: Discontinue one being taken and begin the other at the next scheduled dose.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Apixaban is a substrate of both CYP3A4 and P-gp. Inhibitors of CYP3A4 and P-gp increase exposure to Apixaban and increase the risk of bleeding. Inducers of CYP3A4 and P-gp decrease exposure to Apixaban and increase the risk of stroke.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Apixaban is contraindicated in patients with the following conditions: Active pathological bleeding. Severe hypersensitivity reaction to Apixaban (i.e. anaphylactic reactions).পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Apixaban can cause a skin rash or severe allergic reaction.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: There are no adequate and well-controlled studies of Apixaban in pregnant women. Treatment is likely to increase the risk of hemorrhage during pregnancy and delivery. Apixaban should be used during pregnancy only if the potential benefit outweighs the potential risk to the mother and fetus.Labor and Delivery: Safety and effectiveness of Apixaban during labor and delivery have not been studied in clinical trials. Consider the risks of bleeding and of stroke in using Apixaban in this condition.
Nursing Mothers: It is unknown whether Apixaban or its metabolites are excreted in human milk. Women should be instructed either to discontinue breastfeeding or to discontinue Apixaban therapy, taking into account the importance of the drug to the mother.
সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Increased Risk of Stroke with Discontinuation of Apixaban Discontinuing Apixaban in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. An increased rate of stroke was observed during the transition from Apixaban to warfarin in clinical trials in patients with nonvalvular atrial fibrillation. If Apixaban must be discontinued for a reason other than pathological bleeding, consider coverage with another anticoagulant.মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no antidote to Apixaban. Overdose of Apixaban increases the risk of bleeding. Activated charcoal may be useful in the management of Apixaban overdose.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep in a dry place and store below 30°C. Protect from light and keep out of the reach of children.বিকল্প ব্র্যান্ড: Apixaban
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।